American Association for Cancer Research
00085472can093092-sup-meth_figlegs_1-6.pdf (29.32 kB)

Supplementary Methods, Figure Legends 1-6 from An Oncogenic Role for ETV1 in Melanoma

Download (29.32 kB)
journal contribution
posted on 2023-03-30, 20:07 authored by Judit Jané-Valbuena, Hans R. Widlund, Sven Perner, Laura A. Johnson, Aurora C. Dibner, William M. Lin, Alissa C. Baker, Rosalynn M. Nazarian, Krishna G. Vijayendran, William R. Sellers, William C. Hahn, Lyn M. Duncan, Mark A. Rubin, David E. Fisher, Levi A. Garraway
Supplementary Methods, Figure Legends 1-6 from An Oncogenic Role for ETV1 in Melanoma



Copy gains involving chromosome 7p represent one of the most common genomic alterations found in melanomas, suggesting the presence of “driver” cancer genes. We identified several tumor samples that harbored focal amplifications situated at the peak of common chromosome 7p gains, in which the minimal common overlapping region spanned the ETV1 oncogene. Fluorescence in situ hybridization analysis revealed copy gains spanning the ETV1 locus in >40% of cases, with ETV1 amplification (>6 copies/cell) present in 13% of primary and 18% of metastatic melanomas. Melanoma cell lines, including those with ETV1 amplification, exhibited dependency on ETV1 expression for proliferation and anchorage-independent growth. Moreover, overexpression of ETV1 in combination with oncogenic NRASG12D transformed primary melanocytes and promoted tumor formation in mice. ETV1 overexpression elevated microphthalmia-associated transcription factor expression in immortalized melanocytes, which was necessary for ETV1-dependent oncogenicity. These observations implicate deregulated ETV1 in melanoma genesis and suggest a pivotal lineage dependency mediated by oncogenic ETS transcription factors in this malignancy. Cancer Res; 70(5); 2075–84

Usage metrics

    Cancer Research



    Ref. manager